BLGO
What one share of Biolargo holds
Chemicals and Allied Products
We have included important risks and uncertainties in the cautionary statements included in this Annual Report; particularly, the section titled “Risk Factors” incorporated by reference herein. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections or expectations prove incorrect, actual results, performance or financial condition may vary materially and adversely from those anticipated, estimated or expected.
Biolargo’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.05 |
| Cash and investments | $0.01 |
| Debt | $0.01 |
| Book value | −$0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.00 | −$0.09 | — | −$0.04 | — | −$0.01 |
| 2017 | $0.01 | −$0.10 | $0.00 | −$0.04 | — | −$0.04 |
| 2018 | $0.01 | −$0.09 | — | −$0.03 | — | −$0.01 |
| 2019 | $0.01 | −$0.08 | — | −$0.03 | — | −$0.01 |
| 2020 | $0.01 | −$0.05 | — | −$0.02 | — | $0.02 |
| 2021 | $0.01 | −$0.03 | — | −$0.02 | — | $0.02 |
| 2022 | $0.02 | −$0.02 | — | −$0.01 | — | $0.02 |
| 2023 | $0.04 | −$0.01 | — | −$0.01 | — | $0.02 |
| 2024 | $0.06 | −$0.01 | — | −$0.01 | — | $0.03 |
| 2025 | $0.03 | −$0.04 | — | −$0.03 | — | $0.01 |